Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its ...
WAKIX® (pitolisant) Net Revenue of $154.6 Million for First Quarter 2024; ~30% Growth Year-over-Year
United Kingdom United States Luis Sanay Jeffreym Dayno Epygenix Therapeutics Inc Exchange Commission
Source: eagletribune.com